Jessica Wan, BS

Scientist
Foghorn Therapeutics

I am from the Boston area and am currently a Scientist in the Translational Medicine group at Foghorn Therapeutics in Cambridge, MA. I am interested in identifying clinically-relevant biomarkers that show the drug is hitting the target and having an impact on the tumor cells and disease. Please reach out if you have any questions.

Poster(s):

• (P 187) PRECLINICAL VALIDATION OF TARGET ENGAGEMENT ASSAYS AND INVESTIGATION OF MECHANISTIC IMPACTS OF FHD-609, A CLINICAL-STAGE BRD9 DEGRADER BEING DEVELOPED FOR THE TREATMENT OF SYNOVIAL SARCOMA